BRINGING YOU INFORMATION.  PROVIDING YOU A PLATFORM.

 

 
THE PHARMA REVIEW (JULY – AUG 2018)

Evaluation of Efficacy of “Multani Sundari Jeevak” in The Management of Dysmenorrhoea

Dr. Anita Kumari Satyarthi*, Dr. H. S. Tiwari# & Dr. Pooja Mehta#

Introduction: The purpose of the clinical trial is primarily to establish the efficacy and demonstrate freedom from unwanted side effects in human. Although most early periods are anovulatory and are not painful, nevertheless some girl experience dysmenorrhoea apparently from very soon after the menarche. Dysmenorrhoea is the most common gynaecological complaint of young women. Some degree of dysmenorrhoea is experienced by up to 80% of adolescents within five years of menarche, so it is difficult to identify the small proportions with a pathological cause. The recognition that the prosta glandins release is intrinsic to the process of endometrial breakdown and relates closely to pain. The condition dysmenorrhoea can occur to any girl though stress and psychological factors may influence ability to cope. In Ayurvedic context as far as the ailment ‘Kashtartava’ is concerned, it is not coded as an individual disease. But there are many diseases, in which it is described as a symptom. Though, Chakrapani quoted that any symptom may manifest as an individual disease. Keeping this panorama in mind and looking at the prevalence of the ailment an attempt has been made to study the disease “Kashartava” as a separate entity.

 

Go to Content Index Page

PHARMA REVIEW - ARTICLES ARCHIVE ( COMPLETE LIST)

 

The above content is an abstract only. For the full Article please contact:
KONGPOSH Publications Pvt. Ltd.
ICS House, C-19, Commercial Complex, SDA, Opp. IIT Gate, New Delhi, India -110016
Tel.: 26855839, 9811195411
Email: kongposhpub@gmail.com, Website: http://www.kppub.com

 
 
 
 

Copyright © KONGPOSH PUBLICATIONS Pvt. Ltd.